Castle Biosciences, Inc. · NASDAQ:CSTL

Juvenal Tobin W sold 6,600 Castle Biosciences, Inc. shares (Form 4)

Traded Sep 14 to Sep 15, 2026 · Filed Sep 16, 2026

From Sep 14 to Sep 15, 2026, Juvenal Tobin W (Chief Commercial Officer) sold 6,600 Castle Biosciences, Inc. shares at an average US$33.73 for US$223K under a trading plan, leaving 58,584 shares. Filed Sep 16, 2026 (Form 4).

Sold
6,600 shares
Price
US$33.73 average (US$32.32 to US$35.14)
Value
US$223K
Holding after
58,584 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Commercial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 14, 2026Common StockSale3,306US$32.3261,878Direct
Sep 15, 2026Common StockSale3,294US$35.1458,584Direct

Source

View original at SEC

Related